You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Sulfinpyrazone - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for sulfinpyrazone and what is the scope of patent protection?

Sulfinpyrazone is the generic ingredient in two branded drugs marketed by Novartis, Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for sulfinpyrazone.

Summary for sulfinpyrazone
Recent Clinical Trials for sulfinpyrazone

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
China Medical University HospitalPhase 2

See all sulfinpyrazone clinical trials

Medical Subject Heading (MeSH) Categories for sulfinpyrazone

US Patents and Regulatory Information for sulfinpyrazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087667-001 May 26, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Par Pharm SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 088933-001 Sep 6, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis ANTURANE sulfinpyrazone TABLET;ORAL 011556-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Pharms SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087769-001 Jun 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 087666-001 Sep 17, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Pharms SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 087770-001 Nov 19, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.